Skip to main navigation Skip to search Skip to main content

A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.

Translated title of the contribution: A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.
  • M.P.J.K. Lolkema
  • , H.T. Arkenau
  • , K. Harrington
  • , P. Roxburgh
  • , R. Morrison
  • , V. Roulstone
  • , K. Twigger
  • , M. Coffey
  • , K. Mettinger
  • , G. Gill
  • , T.R. Evans
  • , J.S. de Bono

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer.
Original languageUndefined/Unknown
Pages (from-to)581-588
Number of pages8
JournalClinical Cancer Research
Volume17
Issue number3
Publication statusPublished - 2011

Cite this